Aspivix

Aspivix is a Swiss medical device company focused on enhancing women's healthcare through innovative gynecological devices. Founded in 2015 and based in Renens, Switzerland, Aspivix aims to create modern solutions for common gynecological procedures that often cause discomfort. Their flagship product, Carevix™, is the first suction cervical stabilizer designed to reduce pain and bleeding during procedures like IUD insertion and biopsies. Carevix replaces traditional instruments, significantly decreasing pain by 73% and bleeding by 78%. This device has received FDA clearance and is being introduced in Switzerland in collaboration with Bayer, with plans for entry into the U.S. market by the end of 2024. Aspivix is committed to improving the patient experience and modernizing gynecology by developing technology that respects women's anatomy and comfort. The company is supported by various investors and innovation programs, emphasizing its dedication to advancing women's health.

• Employees 17
• Founded 2015
• Annual Revenue $2500000
• Total Funding $9385630